9 citations,
January 2018 in “Indian Journal of Endocrinology and Metabolism” The study investigated the association between androgenetic alopecia (AGA) and metabolic syndrome (MetS) in 100 patients with AGA and 100 controls at a tertiary care hospital in South India. It found a significantly higher prevalence of MetS in AGA cases (53%) compared to controls (17%) and a positive correlation between the severity of AGA and MetS prevalence. The study concluded that AGA is significantly associated with MetS, suggesting that early screening for MetS in AGA patients could help prevent future complications through early lifestyle modifications.
7 citations,
November 2017 in “Indian Journal of Dermatology, Venereology and Leprology” 6 citations,
September 2019 in “Indian Journal of Dermatology” 6 citations,
January 2016 in “International Journal of Trichology” The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.
5 citations,
February 2021 in “JCPSP. Journal of the College of Physicians & Surgeons Pakistan” 3 citations,
November 2021 in “Frontiers in Medicine” 3 citations,
January 2021 in “Indian Dermatology Online Journal” FUE is a versatile hair transplant technique with many uses and good outcomes when performed with skill.
2 citations,
September 2021 in “Clinical, Cosmetic and Investigational Dermatology” The study examined the prevalence of androgenetic alopecia (AGA) among 297 hospital staff and 318 individuals from the general population at Fuping Hospital in China. It found a higher overall prevalence of AGA in hospital staff (23.6%) compared to the general population (14.8%), with male staff showing a significantly higher prevalence (42.9%) than males in the general population (27.5%). No significant difference was observed among women. The most common types of AGA were type IV and type IIIv in male staff and type I in female staff. The study suggested that occupation-related factors might contribute to the higher prevalence of AGA among hospital staff and recommended further research with a larger sample size to explore related risk factors.
1 citations,
August 2022 in “Frontiers in Medicine” 1 citations,
January 2013 in “Advanced Biomedical Research” Men with more severe hair loss had a lower risk of schizophrenia, but hair loss and testosterone levels were not linked.
April 2024 in “Nigerian Postgraduate Medical Journal” Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.
March 2024 in “Journal of clinical medicine” Trichoscopy shows hair diameter variability, vellus hairs, and the peripilar sign are key indicators for diagnosing Androgenetic Alopecia.
March 2024 in “Indian Journal of Dermatology/Indian journal of dermatology” Using animal names for skin conditions helps with learning and memory.
January 2024 in “Journal of Cosmetic Dermatology” Men's and women's pattern hair loss progress differently, with men showing more hair thinning and women having more widespread hair loss.
August 2023 in “The American Journal of the Medical Sciences” Men with male pattern baldness have higher uric acid levels, which can decrease with finasteride treatment.
July 2023 in “International journal of trichology” Cellcurin therapy with microneedling increases hair density and thickness in treating hair loss in men and women.
June 2023 in “Frontiers in Medicine” Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.
October 2020 in “Benha Journal of Applied Sciences” Troponin I may help detect heart problems in people with Androgenetic Alopecia.
PRP is effective for treating hair loss in men.
June 2022 in “Plastic and reconstructive surgery. Global open” PRP treatment for hair loss improves quality of life and emotional well-being.
July 2021 in “JOURNAL OF THE MEDICAL ASSOCTATION OF THAILAND” Using minoxidil daily with monthly minoxidil mesotherapy is more effective for hair loss than monthly PRP microneedling treatments.
May 2019 in “Journal of the Egyptian Women's Dermatologic Society (Print)” February 2014 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” 48 citations,
January 2017 in “International Journal of Trichology” Microneedling with platelet-rich plasma and minoxidil improves hair growth more than just minoxidil in men with hair loss.
31 citations,
July 2017 in “Stem cell investigation” Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.
13 citations,
January 2019 in “Indian Journal of Dermatology” The study investigated the clinical profile of androgenic alopecia (AGA) and its association with cardiovascular risk factors in men aged 25-40 years, involving 50 men with early-onset AGA and 50 controls. Results showed that metabolic syndrome (MetS) was present in 10% of AGA cases compared to 2% of controls, though not statistically significant. However, AGA patients had significantly higher rates of abdominal obesity, hypertension, and lowered high-density lipoprotein levels. The study concluded that men with early-onset AGA had a higher prevalence of cardiovascular risk factors, suggesting that early screening for MetS and its components could be beneficial for these patients.
3 citations,
November 2021 in “Clinical, Cosmetic and Investigational Dermatology” Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.
3 citations,
January 2021 in “Plastic and Aesthetic Research” Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.
1 citations,
July 2024 in “Skin Research and Technology” Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.